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Abstract 
Bovine leukemia virus-transformed lamb embryo fibroblasts (line FLK) possess activity of DT-diaphorase of ca. 260 U/mg protein 
and similar levels of other NADP(H)-oxidizing enzymes: NADH:oxidase, 359 U/mg; NADPH:oxidase, 43 U/mg; NADH:cytochrome-c 
reductase, 141 U/mg; NADPH:cytochrome-c reductase, 43 U/mg. In general, the toxicity of aromatic nitrocompounds towards FLK 
cells increases on increase of single-electron reduction potentials (E~) of nitrocompounds or the log of their reduction rate constants by 
single-electron-transferring enzymes, microsomal NADPH:cytochrome P-450 reductase (EC 1.6.2.4) and mitochondrial NADH:ubiquinone 
reductase (EC 1.6.99.3). No correlation between the toxicity and reduction rate of nitrocompounds by rat liver DT-diaphorase (EC 
1.6.99.2) was observed. The toxicity is not significantly affected by dicumarol, an inhibitor of DT-diaphorase. Nitrocompounds examined 
were poor substrates for DT-diaphorase, being 10 4 times less active than menadione. Their poor reactivity is most probably determined 
by their preferential binding to a NADPH binding site, but not to menadione binding site of diaphorase. These data indicate that at 
comparable activities of DT-diaphorase and single-electron-transferring NAD(P)H dehydrogenases in the cell, the toxicity of nitrocom- 
pounds will be determined mainly by their single-electron reduction reactions. 
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I. Introduction 
It is generally accepted that tumours and virus-trans- 
formed cells are more prooxidant, i.e., possess decreased 
activities of antioxidant enzymes superoxide dismutase 
(EC 1.15.1.1), catalase (EC 1.11.1.6) and glutathione per- 
oxidase (EC 1.19.1.9) [1-4]. Previously we and others 
showed that the activities of certain O/-and H202-gener- 
ating enzymes, e.g., NAD(P)H oxidases [5,6] or flavin 
dehydrogenases-electrontransferases (NAD(P)H: cy- 
tochrome-c reductases) are higher in transformed cells [6]. 
Recently, a 6-fold increase: of O/-generation rate has been 
observed after the infection of HL-60 cells with human 
Abbreviations: TN, turnover number; TN/Km, bimolecular rate con- 
stant; E~, single-electron reduction potential; BLV, bovine leukemia 
virus; FLK, BLV-transformed lamb embryo kidney fibroblast line; P-450 
R, NADPH:cytochrome P-450 reductase; CoQ R, NADH:ubiquinone 
reductase; cL50, concentration f compound for 50% survival of the cells. 
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immunodeficiency virus-1 [7], most probably due to in- 
creases in the content of cytosolic factors activating mem- 
brane NADPH oxidase. These changes of enzyme activi- 
ties sometimes make transformed cells more susceptible to 
the redox cycling of quinoidal compounds [1,6,8]. On the 
other hand, transformed cells also possess elevated activi- 
ties of DT-diaphorase (EC 1.6.99.2), most probably due to 
induction of its biosynthesis by increased concentrations of
H20 2 [9,10]. This enzyme also participates in bioactiva- 
tion of quinones and aromatic nitrocompounds, reducing 
them to hydroquinones and hydroxylamines, respectively 
[10]. 
The cytotoxicity of aromatic nitrocompounds is often 
caused by redox cycling of nitroradicals formed after a 
single-electron reduction by low-potential NAD(P)H- 
oxidizing flavin dehydrogenases-electrontransferases and 
iron-sulfur proteins [l 1-14]. The cytotoxic hydroxyl- 
amines might be formed under aerobic conditions as well, 
due to competition between the reoxidation and dispropor- 
tionation of nitroradicals [15]. The increase of aerobic 
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toxicity of nitrocompounds upon increase of their single- 
electron reduction potential (E~) has been reported in 
several cases [11,14], pointing out the importance of their 
initial single-electron reduction. On the other hand, mam- 
malian DT-diaphorases can also contribute to the aerobic 
cytotoxicity of nitroaromatic compounds. The latter mech- 
anism explains the antitumour activity of CB-1954 (5- 
(aziridin-l-yl)-2,4-dinitrobenzamide) to Walker cells 
[10,16] and genetoxicity of dinitropyrenes [17]. The dis- 
crimination between these two mechanisms of nitrocom- 
pound cytotoxicity is especially important for transformed 
cells that often possess elevated levels of DT-diaphorase 
and single-electron transferring enzymes. 
We have shown previously [6] that bovine leukemia 
virus (BLV)-transformed fibroblasts possess about 10-fold 
increased activity of DT-diaphorase as compared to non- 
transformed cells. However, the activities of NAD(P)H 
oxidases and NAD(P)H: cytochrome-c reductases also in- 
crease, being comparable to that of DT-diaphorase. These 
changes of enzyme activity increased the sensitivity of 
transformed cells to redox cycling quinones by several 
times. The aim of this paper is an evaluation of the role of 
DT-diaphorase and single-electron-transferring NAD(P)H- 
dehydrogenases in the toxicity of aromatic nitrocompounds 
to FLK cells. 
2. Mater ia l s  and  methods  
The culture of BLV-transformed lamb embryo kidney 
fibroblasts (line FLK) was grown and maintained in Eagles 
medium supplemented with 10% fetal bovine serum at 
37°C as described previously [18,19]. In cytotoxicity ex- 
periments, cells were grown in the presence of various 
amounts of nitrocompounds for 24 h, trypsinized and 
counted using a haemocytometer with viability determined 
by exclusion of Trypan blue. Unattached ead cells were 
removed prior to trypsinization. The activities of 
NAD(P)H-oxidizing enzymes determined in cell lysates [6] 
were close to previously reported values [6]: 
NADH:oxidase, 359 + 5 nmol NADH per mg protein per 
min; NADPH:oxidase, 43 + 6 nmol NADPH per mg pro- 
tein per min; NADH:cytochrome-c reductase, 141_ 8 
nmol cytochrome-c per mg protein per min; NADPH:cyto- 
chrome-c reductase, 43 + 1 nmol cytochrome-c per mg 
protein per min, DT-diaphorase, 260 + 50 nmol dichloro- 
phenolindophenol per mg protein per min at 25°C. 
Rat liver NADPH:cytochrome P-450 reductase (EC 
1.6.2.4) prepared as described previously [20], was a gen- 
erous gift of Dr. K. Ollinger (University of LinkSping, 
Sweden). Its concentration was determined spectrophoto- 
metrically using E460 = 22 mM per cm. DT-diaphorase 
(EC 1.6.99.2) was purified from rat liver after the induc- 
tion with 3-methylcholanthrene [21] by Cibacron Blue 
affinity chromatography [22]. The concentration f DT-di- 
aphorase was determined according to e460 = 11 mM per 
R 
02 N~O~O ]~-CH=CH ~
I R = - CONHCH(CH3 )C3H6N(C2Hs)2  
II R = COOH 
N----zr-CONHN=C( H 3 
III ~ IN~_N02 )2 
H 
Fig. 1. The formulae of some uncommonly used nitrocompounds. 
cm. NADH:ubiquinone reductase from bovine heart mito- 
chondria (EC 1.6.99.3) was prepared according to Hatefi 
and Rieske [23]. 
Nifuroxime and nitrofurantoin (Polfa, Poland), NADH, 
NADPH, cytochrome-c, glucose-6-phosphate (Serva), 
dicumarol, menadione, tetramethyl-l,4-benzoquinone 
(Sigma), 5,8-dihydroxy-l,4-naphthoquinone (Fluka AG), 
ubiquinone-1 (Ferak), glucose oxidase, glucose-6-phos- 
phate dehydrogenase and catalase (Fermentas, Vilnius) 
were used as received. 4-Nitroacetophenone, 4-nitroben- 
zaldehyde and 4-nitrobenzoic acid (Reakhim, Russia) were 
recrystallized from benzone or ethanol, nitrobenzene (Re- 
akhim) was distilled in vacuum. Nitrofurans I and II (Fig. 
1) were synthesized by Dr. N.M. Sukhova (Institute of 
Organic Synthesis, Riga, Latvia), nitroimidazole III (Fig. 
1) was synthesized by Drs. I.S. Selezneva nd V.F. Gryazev 
(Ural Polytechnic Institute, Ekaterinburg, Russia), 3,5-di- 
nitrobenzamide was synthesized by Dr. V. Mi~kinienb 
(Institute of Biochemistry, Vilnius). 
All kinetic measurements were carried out in 0.1 M 
K-phosphate buffer solution (pH 7.0) containing 1 mM of 
EDTA at 25°C. The rates of quinone-and nitroreductase 
reactions of NADPH:cytochrome P-450 reductase and 
NADH:ubiquinone reductase were monitored according to 
a decrease of NAD(P)H absorption (AE34 0 = 6.2 mM per 
cm, concentration of NAD(P)H, 20-100 /zM) using a 
Hitachi-557 spectrophotometer. The reaction rates were 
also measured according to the decrease of NAD(P)H 
fluorescence intensity at 440 nm (excitation wavelength, 
340 nm) using a MPF-4 spectrofluorimeter (Hitachi) when 
the absorption of the nitrocompound in the 340 nm region 
was significant. 
In experiments with DT diaphorase, Tween 20 (0.01%) 
and bovine serum albumin (0.25 mg per ml) were used as 
activators [24]. The rates of reduction of nitrobenzenes 
were monitored spectrophotometrically ccording to a de- 
crease of absorption of NADPH (100 /zM). The rates of 
reduction of nitrofurans and nitroimidazole III (Fig. 1) 
were monitored spectrophotometrically ccording to a de- 
crease of absorbance of nitrocompounds with the use of 
the NADPH regenerating system (2 mM glucose-6-phos- 
phate, 10 /zM NADPH, and 10 /zg ml -1  glucose-6- 
phosphate dehydrogenase). In anaerobic reduction experi- 
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ments, anaerobic onditions were achieved by the addition 
of 10 mM glucose, 50 nlvl glucose oxidase and in some 
cases, 30 /zg per ml catalase. NADPH:oxidase activity of 
DT-diaphorase in the absence or presence of nitrocom- 
pounds was monitored using Clark electrode. The rates of 
quinone reductase reaction of DT-diaphorase were moni- 
tored using hydroquinone-mediated reduction of cy- 
tochrome-c (50 /xM) according to an increase of its ab- 
sorbance at 550 nm (Ae  ::  20 mM per cm) [22,24]. 
The kinetic parameters of the reaction, turnover number 
(TN) and the bimolecular ate constant (TN/K  m) corre- 
spond to the reciprocal intercepts and slopes of the 
Lineweaver-Burk plots. "[/q corresponds to the number of 
NAD(P)H oxidized or cytochrome-c reduced by active 
center of enzyme per 1 s. TN of cytochrome P-450 reduc- 
tase (P-450R) determined according to a reduction of 
cytochrome-c [20] (concentration of cytochrome-c, 50/zM,  
NADPH, 50 /zM) was 36 s -~ TN of DT-diaphorase 
determined according to menadione-mediated r uction of 
cytochrome-c [22,24] wa,; 2000 s-1 (concentration of cy- 
tochrome-c, 50 /xM, NADPH, 100 /zM, and menadione, 
10 /zM). The activity of NADH:ubiquinone reductase 
(CoQ R) determined as a rate of rotenone-sensitive reduc- 
tion of ubiquinone-1 [23] was 0.75 /zmol of NADH oxi- 
dized per mg protein per min (concentration of NADH, 
100 /zM, ubiquinone-l, 50 /xM). Since CoQ R contains 
1.2 nmol of FMN per mg protein [25], TN of CoQ R in 
rotenone-insensitive reduction of 5,8-dihydroxy-l,4-naph- 
thoquinone (100 /xM) by NADH (100 ~M)  [26] was 75 
S -1  " 
3.  Resu l ts  
During 24 h incubation, nitrocompounds investigated 
decreased the viability of FLK cells in a concentration-de- 
J 
I 01. t ]-I~0 110 10D 1000 
[Nitrocompound] (/zM) 
Fig. 2. Survival of FLK cells after 24 h growth in the presence ofvarious 
concentrations of 4-nitroacetophenone (1), nifuroxim (2), and nitrofuran I 
(Fig. 1) (3). 
pendent manner (Fig. 2). The concentrations of nitrocom- 
pounds for the 50% survival of the cells (cLs0) are pre- 
sented in Table 1. The comparison of cLs0 of nitrocom- 
pounds and available values of their single-electron reduc- 
tion potentials (E~) (Table 1) reveals that the cytotoxicity 
of nitrocompounds increases on increase of their E 1. The 
values of cLs0 of some selected nitrocompounds were 
about 1.5-fold increased in the presence of 20 /zM 
dicumarol, an inhibitor of DT-diaphorase, making up 182 
+__ 65 /xM (nitrofuran II, Fig. 1) and 120 +__ 55/xM (3,5-di- 
nitrobenzamide). However, the toxicity of nifuroxime was 
unchanged. This concentration of dicumarol did not affect 
the cell viability. 
As shown previously [13,26,27], nitrocompounds act as 
substrates for two important single-electron transferring 
enzymes, NADPH:cytochrome P-450 reductase and 
NADH:ubiquinone reductase. The latter reaction is not 
inhibited by rotenone (2 /zM). The turnover number for 
the reduction of most reactive nitrocompounds are close to 
the TN of quinone reduction, 70-80 s-  ~ for CoQ R and 18 
s-~ for P-450 R. TN/K  m of nitrocompounds examined 
Table 1 
Single-electron reduction potenlials of nitrocompounds and quinones (E~), their concentrations for 50% survival of FLK cells (cLs0), and bimolecular rate 
constants of their reduction (TN/K m) by NADPH:cytochrome P-450 reductase (P-450 R) and NADH: ubiquinone r ductase (CoQ R) (pH 7.0, 25°C) 
Compound E~ (V) a cLs0 (/~M) TN/K m (M- Is- t) 
P-450 R CoQ R 
2,5-Dihydroxy- 1,4-naphthoquinone - 0.11 0.11 + 0.06 c 
Tetramethyl-l,4-benzoquinone -0.26 16 + 3 c 
Nifuroxime -0.26 4.9 + 2.2 
Nitrofurantoin - 0.26 120 + 36 
4-Nitrobenzaldehyde - 0.33 25 _+ 12 
4-Nitroacetophenone - 0.36 166 :k 36 
4-Nitrobenzoic a id -0.43 780 ± 390 
Nitrobenzene - 0.48 4370 ± 2470 
Nitrofuran I (Fig. 1) - 1.3 __. 0.5 
3.5-dinitrobenzamide - 89 ± 35 
Nitrofuran II (Fig, 1) - 127 5:27 
Nitroimidazole III (Fig. 1) - 127 + 27 
2.10" 107 
1.4 106 
6.1 10 4 
6.1 10 4 
2.5 10 4 
7.1 10 3 
1.1 10 3 
1.6 102 
2.0 105 
1.0 105 
2.5 10 4 
3.6 103 
8.3 • 105 b 
1.7 • 104 b 
3.3 • 104 b 
3.2 • 103 b 
1.2 • 104 b 
7.5 " 102 b 
6.5 • 10 b 
1.1 - 10 2b 
3.7.104 
5.0. 103 
7.7. 10 3 
1.0" 103 
a From Refs. [11,26]. 
b Determined previously [26]. 
c According to our previous data [6]. 
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are presented in Table 1. It also contains the values of cLs0 
of 5,8-dihydroxy- 1,4-naphthoquinone and tetramethyl- 1,4- 
benzoquinone determined for FLK cells in our previous 
work [6], and their TN/K  m values. 
Nitrocompounds examined were poor substrates for 
DT-diaphorase. The most active substrate, nitrofuran II 
(Fig. 1) was slowly reduced by DT-diaphorase in aerobic 
conditions in the presence of a system for the regeneration 
of NADPH (Fig. 3). The reaction rate was unchanged in 
anaerobic conditions; however, it was inhibited almost 
completely by 20 /.tM dicumarol. The initial reaction rate 
was proportional to the concentration f nitrofuran (25-100 
heM) giving TN/K  m of 133 M- i s  - 1. The presence of 30 
/.tg per ml catalase did not affect the rates of anaerobic or 
aerobic reduction. The identification of product(s) of re- 
duction of nitrofuran was not the aim of this study. How- 
ever, one must note that anaerobic reduction of nitrofuran 
II by dithionite or NADPH:cytochrome P-450 reductase 
and the system of regeneration of NADPH gives analogous 
spectra of products with a transient rise of absorption at 
310-330 nm that decreases afterwards (t~/2 = 3-4 h) to a 
level similar to that presented in Fig. 3. Other nitrofurans 
and nitroimidazole III were 5-6 times less active than 
nitrofuran II. After the correction for the intrinsic 
NADPH:oxidase activity of DT-diaphorase, the kinetic 
parameters of nitrobenzenes determined in the spectropho- 
tometric assays of NADPH oxidation were following: 3,5- 
dinitrobenzamide, TN = 0.12 s- ~ TN/K  m = 60 M-  i s-  I. 
4-nitrobenzaldehyde, TN = 0.1 s - l ,  TN/Km : 50 
M-  ~ s- l, 4-nitroacetophenone, TN = 0.06 s- ~, TN/K  m = 
86 M- i s - l ;  4-nitrobenzoic acid, TN = 0.05 s - l ,  TN/K  m 
= 100 M-~s- l ;  nitrobenzene, TN = 0.06 s -1, TN/K  m = 
24 M- is -~.  One should note that nitrocompounds investi- 
gated did not affect the NADPH:oxidase activity of DT-di- 
aphorase, 0.05 s-~, when monitored using Clark electrode 
(concentration of nitrofurans, 100 /xM; concentration of 
nitrobenzenes, 1.0 mM). For comparison, at saturating 
°~ 1.2 
0.8 ,.Q 
< 
0.4 
i i 
310 370 430 490 
Wavelength (nm)  
Fig. 3. The aerobic reduction of 100 txM of nitrofuran II (Fig. 1) by 
DT-diaphorase (145 nM) in the presence of NADPH (10 /xM) and 
NADPH-regenerating system: initial spectrum (1), spectrum after 20 h 
incubation (2). 
0.012 
A ~j /e  
"~" 0.008 4 v 
> 3 
~r3 
0.004 
1 2 3 4 5 
1/[NADPH] 10 -4  (M -1) 
5 
2 
1 
0.006 
3, 
> 0.004 
0.002 
]3 
5 
3 
0.5 t.0 1.5 
1/[Menadionv] 10 -6  (M -1) 
Fig. 4. The competitive to NADPH (A) and uncompetitive to menadione 
(B) inhibition of DT-diaphorase by nitrofuran II (Fig. 1). (A) Concentra- 
tion of menadione, l0 IxM, concentration of cytochrome-c, 50 p.M, 
concentrations of nitrofuran, 0 /zM (1), 50 /zM (2), 100 p.M (3), 150 
/xM (4) and 200 /xM (5). (B) Concentration of NADPH, 40 /xM, 
concentrations of cytochrome-c and nitrofuran -the same as in A. 
concentration of NADPH (100 /xM), TN and TN/K  m of 
quinones were 2000 s- l  and 2.0. 10 9 M- Is  - 1 (2-methyl- 
1,4-naphthoquinone), 1000 s -1 and 1.05. 10 9 M is-1 
(5,8-dihydroxy- 1,4-napthoquinone), 2600 s- i and 5.4 • 108 
M-  l s-  l (tetramethyl- 1,4-benzoquinone, determined ac- 
cording to a rate of hydroquinone-mediated r uction of 
cytochrome-c). 
In agreement with previous observations [16,28], nitro- 
compounds inhibit DT-diaphorase. They act as competitive 
inhibitors to NADPH and uncompetitive inhibitors to 
menadione (Fig. 4). The competitive K i make up 25 /.tM 
for nitrofuran II (Fig. 1), 63 /zM for nitroimidazole III 
(Fig. 1), 350 /.tM for 3,5-dinitrobenzamide, 1.0 mM for 
4-nitrobenzaldehyde and 1.3 mM for nifuroxime. 
4. Discussion 
The data of present work indicate that cLs0 of aromatic 
nitrocompounds towards FLK cells span over 3 orders of 
magnitude (Table 1). On analogy to other data on aerobic 
cytotoxicity of monofunctional noncross-linking nitrocom- 
pounds [11,14], an approximate linear relationship is ob- 
served between log cLs0 and E~ of nitrocompounds and 
quinones investigated (Fig. 5): 
log cLso ( /xM)  = - 1.946 -4- 1.305 - 11.53 4- 3.96E~(V) 
( r = 0.9457) (1) 
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° 4 a if3 
(1.1 
i 
-0.4 -0.3 -0.2 -0.1 
i 
E 7 (v) 
Fig. 5. The relationship between cLs0 of nitrocompounds and quinones to 
FLK cells and their potentials of single-electron reduction: 5,8-dihydroxy- 
1,4-naphthoquinone (1), tetramethyl-l,4-benzoquinone (2), nifuroxime 
(3), nitrofurantoin (4), 4-nitrobenzaldehyde (5), 4-nitroacetophenone (6),
4-nitrobenzoic acid (7), nitrobenzene (8). 
It is supposed that linear relationships between log cLs0 
and E 1 with a proportionality coefficient close to - l0  
V-1 reflect he relative rates of single-electron e zymatic 
reduction of nitrocompounds initiating their redox cycling 
[ll,14] or other reactions, e.g., formation of hydroxyl- 
amines. The linear relationships between log TN/K~, and 
E~ of nitrocompounds have been demonstrated for their 
single-electron reduction by NADPH:cytochrome P-450 
reductase [13,27], ferrodoxin:NADP + reductase [13], 
NADPH:adrenodoxin reductase-adrenodoxin system [29]. 
An analogous although relatively scattered ependence is 
also observed for reactions of quinones and nitrocom- 
pounds with mitochondrial NADH:ubiquinone reductase 
[26]. Since the present study includes a number of nitro- 
compounds with previously undetermined values of E~, we 
have compared their cytotoxicity to the reactivities towards 
two important single-electron transferring enzymes, 
NADPH:cytochrome P-450 reductase and 
NADH:ubiquinone r ductase (Fig. 6). The following linear 
loo 8- ~'~,1o 
1.o 
TN/K m P--450 R (M-Is -1 ) TN/K m CoQR (M-Is - l  ) 
Fig. 6. The relationships between cLs0 of nitrocompounds and quinones 
to FLK cells and the rate conmants of their reduction by NADPH:cyto- 
chrome P-450 reductase (A) and NADH:ubiquinone reductase (B): 5,8-di- 
hydroxy-l,4-naphthoquinone (1), tetramethyl-l.4-benzoquinone (2), ni- 
furoxime (3), nitrofurantoin (4), 4-nitrobenzaldehyde (5), 4-nitroace- 
tophenone (6), 4-nitrobenzoic acid (7), nitrobenzene (8), nitrofuran I (9), 
3,5-dinitrobenzamidc (10), nitrefuran II (11), nitroiminazolc III (12). 
~a  B 
relationships between log cLs0 and log TN/K m were 
observed: 
log cL50 (/xM) 
= 5.473 _+ 1.384 - 0.835 
+0.2911ogTN/Km(M-ls-l)(r=0.8964), (2) 
for NADPH:cytochrome P-450 reductase, and 
log cLso (txM) 
-- 5.469 + 0.945 - 1.039 
+O.2461ogTN/Km(M-ls-1)(r=0.9478), (3) 
for NADH:ubiquinone reductase. It is evident that al- 
though certain specificity exists between these enzymes 
(Fig. 6), the cytotoxicities of nitrocompounds investigated 
in general correlated to their reactivities towards P-450 R 
and CoQ R. It has been suggested [27] that TN/K m of 
quinones and nitrocompounds in their single-electron 
outer-spherical reduction by NADPH:cytochrome P-450 
reductase could be useful for prediction of cytotoxicity 
resulting from bioreductive activation. In our case, how- 
ever, the cytotoxicity was more closely related to the 
reactions of NADH:ubiquinone reductase (Eqn. 2,3). Of 
course, one cannot exclude the participation of other sin- 
gle-electron transferring enzymes, e.g., O~--generating fi-
broblast plasma membrane NADPH oxidase [30] or plasma 
membrane NAD(P)H dehydrogenases [31] in bioactivation 
of nitrocompounds. The possible effects of differences of 
partition coefficients and cellular uptake of compounds 
should also be taken into the account. Nevertheless, the 
absence of relationship between cytotoxicity of nitrocom- 
pounds and their reactivity towards DT-diaphorase is evi- 
dent in our case, since the latter parameter spans no more 
than over one order of magnitude. Besides, the cytotoxicity 
is almost unaffected by inhibitor of DT-diaphorase, 
dicumarol. 
The poor reactivity of aromatic nitrocompounds to- 
wards mammalian DT-diaphorases i well documented 
[10,16,28]. For the reaction of Walker DT-diaphorase with 
5-(aziridin-l-yl)-2,4-dinitrobenzamide (CB-1954), a TN of 
4.1 per min has been reported [16]. The reactivity of 
3,5-dinitrobenzamide is 60% less than CB-1954 [28]. These 
values are comparable to the data of present work. Among 
the possible reasons for the poor reactivity of nitrocom- 
pounds, one can suggest their nonproductive binding in the 
active center of DT-diaphorase. It was proposed that 
NAD(P)H and quinones bind to close although separate 
binding sites of this enzyme [32]. Therefore, the character 
of inhibition of nitrocompounds towards NAD(P)H and 
menadione (Fig. 4) points out the preferential binding of 
nitrocompounds to the NAD(P)H-binding site of oxidized 
enzyme, and not to the quinone binding site of reduced 
enzyme. 
The data of the present work indicate that at moderate 
activities of DT-diaphorase in the cell (260 U/rag) and 
comparable activities of single-electron transferring 
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NAD(P)H-oxidizing enzymes, the cytotoxicity of mono- 
functional noncross-linking aromatic nitrocompounds i  
determined mainly by their single-electron bioactivation, 
rather than by their reactions with DT-diaphorase. In our 
understanding, far higher cellular concentrations of DT-di- 
aphorase are required for its efficient participation i  the 
bioactivation of nitrocompounds. For example, Walker 
carcinoma nd other at cell lines where the role of DT-di- 
aphorase in the bioactivation of CB-1954 is well estab- 
lished [10,16,28], possess activities of DT-diaphorase close 
tO 10 4 U/mg protein[16]. 
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